In contrast to many tumor types, HIF1α and HIF2α have opposite roles in ccRCC biology, where HIF1α acts as a tumor suppressor and HIF2α acts as an oncogene [4]. This evidence concerns the gene HIF1A and nonpapillary renal cell carcinoma.